# Cosmos Health Inc.: filings

COSM · Nasdaq · CIK 1474167 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cosm.md) · [Financials](/companies/cosm/financials.md) · [Filings](/companies/cosm/filings.md) · [Insiders](/companies/cosm/insiders.md)

## Reports and events: 271 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 145, 4 126, 10-Q 49, CORRESP 28, UPLOAD 28, NT 10-Q 21, S-1/A 19, 424B3 18, 10-K 17, 5 17, EFFECT 15, NT 10-K 15, 3 14, 8-K/A 14, SC 13G/A 9, SCHEDULE 13G/A 9, S-1 7, POS AM 6, S-3 6, S-3/A 6, D 5, DEF 14A 5, PRE 14A 5, PRE 14C 5, SC 13D 5, 10-K/A 4, DEF 14C 4, 424B5 3, 4/A 3, DEFA14A 3, S-11/A 3, SC 13D/A 3, SC 13G 3, SCHEDULE 13D/A 3, RW 2, 5/A 1, 8-A12B 1, 8-A12G 1, CERT 1, D/A 1, PRER14A 1, PRER14C 1, S-1MEF 1, S-8 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 11:50 ET | [8-K](/filings/0001477932-26-006396.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-006396 |
| 2026-10-09 | 17:00 ET | [8-K](/filings/0001477932-26-006158.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001477932-26-006158 |
| 2026-08-20 | 17:11 ET | [8-K](/filings/0001477932-26-005195.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001477932-26-005195 |
| 2026-08-18 | 16:31 ET | [10-Q](/filings/0001477932-26-005146.md) | Quarterly report, period 2026-06-30 | 0001477932-26-005146 |
| 2026-07-16 | 16:35 ET | [8-K](/filings/0001477932-26-004357.md) | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-26-004357 |
| 2026-07-06 | 09:30 ET | [8-K](/filings/0001477932-26-004192.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-004192 |
| 2026-06-02 | 16:30 ET | [DEF 14A](/filings/0001477932-26-003588.md) | Proxy statement, period 2026-06-02 | 0001477932-26-003588 |
| 2026-05-22 | 09:30 ET | [8-K](/filings/0001477932-26-003403.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001477932-26-003403 |
| 2026-05-20 | 16:31 ET | [10-Q](/filings/0001477932-26-003357.md) | Quarterly report, period 2026-03-31 | 0001477932-26-003357 |
| 2026-04-16 | 11:15 ET | [8-K](/filings/0001477932-26-002316.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001477932-26-002316 |
| 2026-04-15 | 16:34 ET | [10-K](/filings/0001477932-26-002278.md) | Annual report, period 2025-12-31 | 0001477932-26-002278 |
| 2025-12-18 | 10:23 ET | [8-K](/filings/0001477932-25-009040.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001477932-25-009040 |
| 2025-11-17 | 16:30 ET | [8-K](/filings/0001477932-25-008402.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-008402 |
| 2025-11-14 | 16:32 ET | [10-Q](/filings/0001477932-25-008322.md) | Quarterly report, period 2025-09-30 | 0001477932-25-008322 |
| 2025-10-17 | 11:09 ET | [8-K](/filings/0001477932-25-007629.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-25-007629 |
| 2025-10-06 | 16:20 ET | [8-K](/filings/0001477932-25-007365.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-25-007365 |
| 2025-10-01 | 06:02 ET | [8-K](/filings/0001477932-25-007274.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-25-007274 |
| 2025-09-29 | 09:59 ET | [8-K](/filings/0001477932-25-007111.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-007111 |
| 2025-08-22 | 17:17 ET | [DEF 14A](/filings/0001477932-25-006195.md) | Proxy statement, period 2025-09-30 | 0001477932-25-006195 |
| 2025-08-18 | 18:32 ET | [10-Q](/filings/0001477932-25-005997.md) | Quarterly report, period 2025-06-30 | 0001477932-25-005997 |
| 2025-08-11 | 06:03 ET | [8-K](/filings/0001477932-25-005628.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001477932-25-005628 |
| 2025-08-06 | 11:29 ET | [8-K](/filings/0001477932-25-005501.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-25-005501 |
| 2025-06-03 | 17:07 ET | [S-1/A](/filings/0001477932-25-004386.md) | Registration statement, amended | 0001477932-25-004386 |
| 2025-05-27 | 12:06 ET | [SCHEDULE 13D/A](/filings/0001477932-25-004185.md) | Ownership report, active investor, amended | 0001477932-25-004185 |
| 2025-05-15 | 09:20 ET | [10-Q](/filings/0001477932-25-003730.md) | Quarterly report, period 2025-03-31 | 0001477932-25-003730 |
| 2025-05-07 | 13:30 ET | [8-K](/filings/0001477932-25-003402.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001477932-25-003402 |
| 2025-04-15 | 16:36 ET | [10-K](/filings/0001477932-25-002759.md) | Annual report, period 2024-12-31 | 0001477932-25-002759 |
| 2025-02-28 | 09:00 ET | [SCHEDULE 13D/A](/filings/0001477932-25-001343.md) | Ownership report, active investor, amended | 0001477932-25-001343 |
| 2025-02-18 | 16:51 ET | [8-K](/filings/0001477932-25-001107.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-001107 |
| 2025-02-07 | 16:40 ET | [S-1/A](/filings/0001477932-25-000785.md) | Registration statement, amended | 0001477932-25-000785 |
| 2025-01-29 | 16:50 ET | [8-K](/filings/0001477932-25-000519.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001477932-25-000519 |
| 2025-01-29 | 16:45 ET | [SCHEDULE 13D/A](/filings/0001477932-25-000517.md) | Ownership report, active investor, amended | 0001477932-25-000517 |
| 2025-01-22 | 08:00 ET | [8-K](/filings/0001477932-25-000373.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001477932-25-000373 |
| 2025-01-14 | 06:16 ET | [S-1/A](/filings/0001477932-25-000204.md) | Registration statement, amended | 0001477932-25-000204 |
| 2025-01-10 | 06:13 ET | [S-1/A](/filings/0001477932-25-000125.md) | Registration statement, amended | 0001477932-25-000125 |
| 2025-01-06 | 06:04 ET | [S-1/A](/filings/0001477932-25-000038.md) | Registration statement, amended | 0001477932-25-000038 |
| 2024-12-18 | 17:22 ET | [S-1](/filings/0001477932-24-008191.md) | Registration statement | 0001477932-24-008191 |
| 2024-12-10 | 16:59 ET | [S-1/A](/filings/0001477932-24-007979.md) | Registration statement, amended | 0001477932-24-007979 |
| 2024-11-27 | 17:27 ET | [S-1/A](/filings/0001477932-24-007723.md) | Registration statement, amended | 0001477932-24-007723 |
| 2024-11-21 | 16:30 ET | [8-K](/filings/0001477932-24-007534.md) | 5.07 Shareholder vote results | 0001477932-24-007534 |
| 2024-11-14 | 16:53 ET | [10-Q](/filings/0001477932-24-007222.md) | Quarterly report, period 2024-09-30 | 0001477932-24-007222 |
| 2024-11-14 | 16:44 ET | [S-1/A](/filings/0001477932-24-007216.md) | Registration statement, amended | 0001477932-24-007216 |
| 2024-11-12 | 16:30 ET | [8-K](/filings/0001477932-24-007041.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001477932-24-007041 |
| 2024-10-28 | 17:13 ET | [S-1](/filings/0001477932-24-006693.md) | Registration statement | 0001477932-24-006693 |
| 2024-10-18 | 14:17 ET | [DEF 14A](/filings/0001477932-24-006563.md) | Proxy statement, period 2024-11-19 | 0001477932-24-006563 |
| 2024-09-27 | 21:08 ET | [8-K](/filings/0001477932-24-005967.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001477932-24-005967 |
| 2024-08-19 | 17:05 ET | [10-Q](/filings/0001477932-24-005141.md) | Quarterly report, period 2024-06-30 | 0001477932-24-005141 |
| 2024-08-19 | 15:50 ET | [10-Q](/filings/0001477932-24-005114.md) | Quarterly report, period 2024-03-31 | 0001477932-24-005114 |
| 2024-08-05 | 17:09 ET | [10-K](/filings/0001477932-24-004545.md) | Annual report, period 2023-12-31 | 0001477932-24-004545 |
| 2024-07-22 | 11:26 ET | [8-K](/filings/0001477932-24-004310.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-24-004310 |

Page 1 of 6. [Older](/companies/cosm/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:09 ET. No prices; not investment advice.